Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Dammam University
Sponsor:
Collaborators:
King Fahad Armed Forces Hospital
Dammam Central Hospital
Information provided by (Responsible Party):
Dammam University
ClinicalTrials.gov Identifier:
NCT01823185
First received: March 19, 2013
Last updated: January 20, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)